FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/081558 [Registered on: 03/03/2025] Trial Registered Prospectively
Last Modified On: 02/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To check the effect of Haridradi Anjan application in patients with complaints of Simple Allergic Conjunctivitis  
Scientific Title of Study   Randomized control clinical trial to evaluate the efficacy of Haridradi Anjan in Vataja Abhishyanda w.s.r. to Simple Allergic Conjunctivitis  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pragati Audumbar Sarvade  
Designation  MS Shalakyatantra Scholar  
Affiliation  LKR Ayurvedic Mahavidyalaya Post Graduate Training and Research Center, Gadhinglaj, Kolhapur 
Address  Shalakyatantra department 1 st floor OPD no 49 Late Kedari Redekar Ayurvedic mahavidyalay Gadhinglaj P2 M I D C Area, shendri Mal, Gadhinglaj, Kolhapur

Pune
MAHARASHTRA
410501
India 
Phone  9763654187  
Fax    
Email  sarvadepragati@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Yuvraj Sutar  
Designation  MS Shalakyatantra  
Affiliation  LKR Ayurvedic Mahavidyalaya Post Graduate Training and Research Center, Gadhinglaj, Kolhapur 
Address  Shalakyatantra department 1 st floor OPD no 49 Late Kedari Redekar Ayurvedic mahavidyalay Gadhinglaj P2 M I D C Area, shendri Mal, Gadhinglaj, Kolhapur
Shalakyatantra department 1 st floor OPD no 49 Late Kedari Redekar Ayurvedic mahavidyalay Gadhinglaj P2 M I D C Area, shendri Mal, Gadhinglaj, Kolhapur
Kolhapur
MAHARASHTRA
416505
India 
Phone  9850544418  
Fax    
Email  drsutaryuvrajmsophth@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pragati Audumbar Sarvade  
Designation  MS Shalakyatantra Scholar  
Affiliation  LKR Ayurvedic Mahavidyalaya Post Graduate Training and Research Center, Gadhinglaj, Kolhapur 
Address  Shalakyatantra department 1 st floor OPD no 49 Late Kedari Redekar Ayurvedic mahavidyalay Gadhinglaj P2 M I D C Area, shendri Mal, Gadhinglaj, Kolhapur

Pune
MAHARASHTRA
410501
India 
Phone  9763654187  
Fax    
Email  sarvadepragati@gmail.com  
 
Source of Monetary or Material Support  
Late Kedari Redekari Ayurvedic Mahavidyalaya P.G. Gadhinglaj, P-2, M.I.D.C. Area Shendri Mal, Gadhinglaj  
 
Primary Sponsor  
Name  Dr Pragati Audumbar Sarvade  
Address  Shalakyatantra department 1 st floor OPD no 49 Late Kedari Redekar Ayurvedic mahavidyalay Gadhinglaj  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pragati Audumbar Sarvade   LKR Ayurvedic Mahavidyalaya Gadhinglaj   LKR Ayurvedic Mahavidyalaya P.G. Gadhinglaj,P-2,M.I.D.C. Area Shendri Mal Gadhinglaj Dist-Kolhapur. Shalakyatantra department 1st Floor OPD No.49
Kolhapur
MAHARASHTRA 
9763654187

sarvadepragati@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
LKR Ayurvedic College, Gadhinglaj, Kolhapur   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H101||Acute atopic conjunctivitis. Ayurveda Condition: ABISHYANDAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Haridradi Anjan , Reference: Yogaratnakar , Route: Ocular, Dosage Form: , Dose: 2(NA), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: Haridradi Anjan will be used in vataja Abhishyanda w.s.r. to simple allergic conjunctivitis in the doses of 2 Harenu matra.
2Comparator Arm (Non Ayurveda)-Olopatadine eye drop (0.1%w/v)Olopatadine eye drop belongs to a group of medicines called antihistamine.It is indicated for the symptomatic treatment of ocular itching associated with allergic conjunctivitis as ophthalmic solution. Dose- 2 Drops Frequency-BD (Morning and Evening) Route- Ocular Days- 21 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Age group - 18 to 50 years
The patients presenting classical signs and symptoms of Vataja Abhishyanda  
 
ExclusionCriteria 
Details  Patients having any other known ocular pathology.
Any past or present history of ocular trauma.
Patients with K/C/O Naso lacrimal duct block/ Dacryocystitis) 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To Evaluate the Efficacy of Haridradi Anjan in Vataja Abhishyanda w.s.r. to Simple Allergic conjunctivitis.  21 days 
 
Secondary Outcome  
Outcome  TimePoints 
Adverse reaction if any  21 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   13/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    This study is single blind randomized control clinical study to evaluate the efficacy of Haridradi Anjan in Simple Allergic Conjunctivitis.
Total 60 patients of age 18 to 50 years of both sex will be randomly selected for this trial and divided into two groups.
Group A  Haridradi Anjan 
Dose- 2 Harenu in the evening for 21 days
Group B Olopatadine eye drop 
Dose- 2 Drops in the morning and evening for 21 days
 
Close